Dual-Targeting Nanoplatform Integrating Metabolic Glycan Labeling and Bioorthogonal Chemistry for Precise Delivery of Oxaliplatin to PSMA-Positive Prostate Cancer
- DOI
- 10.1021/acsmacrolett.6c00402
- Published
- 2026-09-14
- Container
- ACS Macro Letters
- Publisher
- American Chemical Society (ACS)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1021/acsmacrolett.6c00402,
title = {Dual-Targeting
Nanoplatform Integrating Metabolic
Glycan Labeling and Bioorthogonal Chemistry for Precise Delivery of
Oxaliplatin to PSMA-Positive Prostate Cancer},
author = {Guoliang Xu and Renhao Chang and Song Huang and Huijiao Ding and Wei Zhang and Songshen Chu and Feiyang Gao and Shankai Zhao and Lianqu Wang and Liqun Zhou and Jing Ma and Jiajia Wang},
year = {2026},
journal = {ACS Macro Letters},
doi = {10.1021/acsmacrolett.6c00402},
url = {https://doi.org/10.1021/acsmacrolett.6c00402}
}RIS
TY - JOUR TI - Dual-Targeting Nanoplatform Integrating Metabolic Glycan Labeling and Bioorthogonal Chemistry for Precise Delivery of Oxaliplatin to PSMA-Positive Prostate Cancer AU - Guoliang Xu AU - Renhao Chang AU - Song Huang AU - Huijiao Ding AU - Wei Zhang AU - Songshen Chu AU - Feiyang Gao AU - Shankai Zhao AU - Lianqu Wang AU - Liqun Zhou AU - Jing Ma AU - Jiajia Wang PY - 2026 JO - ACS Macro Letters DO - 10.1021/acsmacrolett.6c00402 UR - https://doi.org/10.1021/acsmacrolett.6c00402 ER -
APA
Xu, G., Chang, R., Huang, S., Ding, H., Zhang, W., Chu, S., Gao, F., Zhao, S., Wang, L., Zhou, L., Ma, J., & Wang, J. (2026). Dual-Targeting Nanoplatform Integrating Metabolic Glycan Labeling and Bioorthogonal Chemistry for Precise Delivery of Oxaliplatin to PSMA-Positive Prostate Cancer. ACS Macro Letters. https://doi.org/10.1021/acsmacrolett.6c00402
Source records
- crossref · retrieved 2026-11-10T19:06:21.968Z